Aripiprazole Added on for DMDD in Youths With ADHD
Status:
Completed
Trial end date:
2017-08-12
Target enrollment:
Participant gender:
Summary
Objectives:
1. To investigate the effectiveness of adjuvant with aripiprazole to methylphenidate for
disruptive mood dysregulation disorder (DMDD) in youths with
attention-deficit/hyperactivity disorder (ADHD)
2. To investigate the neural basis of chronic irritability in youths with functional
magnetic resonance imaging (fMRI)
3. To compare the clinical characteristics of youths with comorbid ADHD and DMDD to youths
with ADHD only